{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:37:32Z","timestamp":1792276652715,"version":"4.4.0"},"reference-count":21,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>The primary objective of this study was to determine the frequency and nature of complications that occur during intrathecal baclofen (ITB) therapy, including nonsurgical complications as well as complications associated with both implantation surgeries and subsequent revisions.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>The authors retrospectively reviewed the medical records of all patients who had baclofen pumps implanted at a tertiary children\u2019s hospital from 2006 through June 2019. The study employed appropriate descriptive statistics and statistical models to analyze patient demographics, improvements in tone, and clinical complications. The authors evaluated the associations of complications as well as changes in modified Ashworth Scale (MAS) scores with various preexisting conditions (e.g., presence of gastrostomy tubes [G-tubes] and ventriculoperitoneal [VP] shunts) and surgical variations (e.g., use of newer [Ascenda] catheters and subfascial versus subcutaneous catheter tunneling).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>One hundred forty-two pumps were implanted. Complications occurred in 111 patients (78.2%). The most frequent complications were catheter complications and pseudomeningoceles, each of which occurred in 63 (44%) patients. On multivariable analysis, pseudomeningoceles and percutaneous CSF leaks were significantly less likely when intrathecal catheters were placed via laminotomy versus spinal needle (OR 4.6, p = 0.044), and when catheters were passed from the posterior incision to the abdominal pump pocket deep to the thoracolumbar fascia rather than superficial to it (OR 2.7, p = 0.008). Preexisting G-tubes and VP shunts at the time of pump implantation were not associated with a significantly increased likelihood of pump malfunction or infection. Ascenda catheters were significantly less likely to have disconnections (p &lt; 0.001) and obstructions (p = 0.016), and overall were less likely to have any catheter-related complications (p = 0.01). Patients with preexisting VP shunts at the time of implantation had a significantly greater mean decrease in MAS scores in both their lower extremities (1.8, p = 0.003) and upper extremities (1.3, p = 0.002) than did patients without shunts.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>Various complications are associated with ITB therapy, most commonly catheter complications and pseudomeningoceles. There have been fewer catheter complications associated with the newest catheter model, while pseudomeningoceles have become less frequent since the surgical technique was modified to prevent them. VP shunts and G-tubes are not associated with significantly higher complication rates and shunts seem to be associated with greater efficacy of ITB therapy, as represented by a greater mean improvement in MAS scores.<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2024.6.peds23360","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T02:29:02Z","timestamp":1726885742000},"page":"659-670","source":"Crossref","is-referenced-by-count":14,"title":["Complications of intrathecal baclofen therapy in children and young adults"],"prefix":"10.3171","volume":"34","author":[{"given":"Megan V.","family":"Ryan","sequence":"first","affiliation":[{"name":"Departments of Neurosurgery and"},{"name":"Rocky Vista University, College of Osteopathic Medicine, Parker;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey M.","family":"Freeman","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"},{"name":"Departments of Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Blasco","sequence":"additional","affiliation":[{"name":"Neuroscience Institute, Children\u2019s Hospital Colorado, Aurora; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Sawyer","sequence":"additional","affiliation":[{"name":"Physical Medicine & Rehabilitation, Children\u2019s Hospital Colorado, Aurora;"},{"name":"Physical Medicine & Rehabilitation, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Graber","sequence":"additional","affiliation":[{"name":"Neuroscience Institute, Children\u2019s Hospital Colorado, Aurora; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhong","family":"Tong","sequence":"additional","affiliation":[{"name":"Pediatrics, University of Colorado School of Medicine, Aurora;"},{"name":"Colorado School of Public Health, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Oleszek","sequence":"additional","affiliation":[{"name":"Physical Medicine & Rehabilitation, Children\u2019s Hospital Colorado, Aurora;"},{"name":"Physical Medicine & Rehabilitation, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corbett","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery and"},{"name":"Departments of Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"11","key":"b1","series-title":"Biochem Pharmacol","first-page":"1525","article-title":"GABAB receptor trafficking and interacting proteins: targets for the development of highly specific therapeutic strategies to treat neurological disorders?","volume":"86","author":"Benke D","year":"2013","unstructured":"Benke D. GABAB receptor trafficking and interacting proteins: targets for the development of highly specific therapeutic strategies to treat neurological disorders? Biochem Pharmacol. 2013;86(11):1525\u20131530."},{"issue":"12","key":"b2","series-title":"Arch Phys Med Rehabil","first-page":"1721","article-title":"Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications","volume":"83","author":"Murphy NA","year":"2002","unstructured":"Murphy NA, Irwin MCN, Hoff C. Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications. Arch Phys Med Rehabil. 2002;83(12):1721\u20131725."},{"issue":"23","key":"b3","series-title":"N Engl J Med","first-page":"1517","article-title":"Intrathecal baclofen for severe spinal spasticity","volume":"320","author":"Penn RD","year":"1989","unstructured":"Penn RD, Savoy SM, Corcos D,  Intrathecal baclofen for severe spinal spasticity. N Engl J Med. 1989;320(23):1517\u20131521."},{"key":"b4","series-title":"ISRN Neurol","first-page":"575168","article-title":"Complications of intrathecal baclofen pump: prevention and cure","volume":"2012","author":"Awaad Y","year":"2012","unstructured":"Awaad Y, Rizk T, Siddiqui I, Roosen N, McIntosh K, Waines GM. Complications of intrathecal baclofen pump: prevention and cure. ISRN Neurol. 2012;2012:575168."},{"issue":"3","key":"b5","series-title":"Childs Nerv Syst","first-page":"421","article-title":"Intrathecal baclofen therapy: complication avoidance and management","volume":"27","author":"Haranhalli N","year":"2011","unstructured":"Haranhalli N, Anand D, Wisoff JH,  Intrathecal baclofen therapy: complication avoidance and management. Childs Nerv Syst. 2011;27(3):421\u2013427."},{"issue":"1","key":"b6","series-title":"J Pediatr Orthop","first-page":"76","article-title":"Complications of intrathecal baclofen pump therapy in pediatric patients","volume":"30","author":"Borowski A","year":"2010","unstructured":"Borowski A, Littleton AG, Borkhuu B,  Complications of intrathecal baclofen pump therapy in pediatric patients. J Pediatr Orthop. 2010;30(1):76\u201381."},{"issue":"4","key":"b7","series-title":"Pediatr Emerg Care","first-page":"271","article-title":"Baclofen pumps: uses and complications","volume":"33","author":"Woolf SM","year":"2017","unstructured":"Woolf SM, Baum CR. Baclofen pumps: uses and complications. Pediatr Emerg Care. 2017;33(4):271\u2013275."},{"issue":"2","key":"b8","series-title":"J Biomed Inform","first-page":"377","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris PA","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u2013381."},{"key":"b9","series-title":"J Biomed Inform","first-page":"103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris PA","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL,  The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208."},{"issue":"4","key":"b10","series-title":"J Neurosurg Pediatr","first-page":"493","article-title":"Comparison between an Ascenda and a silicone catheter in intrathecal baclofen therapy in pediatric patients: analysis of complications","volume":"18","author":"Motta F","year":"2016","unstructured":"Motta F, Antonello CE. Comparison between an Ascenda and a silicone catheter in intrathecal baclofen therapy in pediatric patients: analysis of complications. J Neurosurg Pediatr. 2016;18(4):493\u2013498."},{"issue":"3","key":"b11","series-title":"Neurosurgery","first-page":"753","article-title":"Subfascial implantation of intrathecal baclofen pumps in children: technical note","volume":"49","author":"Kopell BH","year":"2001","unstructured":"Kopell BH, Sala D, Doyle WK, Feldman DS, Wisoff JH, Weiner HL. Subfascial implantation of intrathecal baclofen pumps in children: technical note. Neurosurgery. 2001;49(3):753\u2013757."},{"issue":"3","key":"b12","series-title":"J Neurosurg Pediatr","first-page":"301","article-title":"Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience","volume":"13","author":"Motta F","year":"2014","unstructured":"Motta F, Antonello CE. Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience. J Neurosurg Pediatr. 2014;13(3):301\u2013306."},{"key":"b13","series-title":"World Neurosurg","first-page":"244","article-title":"A novel skin and fascia opening for subfascial inserting of intrathecal baclofen pump","volume":"110","author":"Fiaschi P","year":"2018","unstructured":"Fiaschi P, Cama A, Piatelli G, Moretti P, Pavanello M. A novel skin and fascia opening for subfascial inserting of intrathecal baclofen pump. World Neurosurg. 2018;110:244\u2013248."},{"issue":"5","key":"b14","series-title":"J Neurosurg Pediatr","first-page":"487","article-title":"Infections related to intrathecal baclofen therapy in children and adults: frequency and risk factors","volume":"4","author":"Fjelstad AB","year":"2009","unstructured":"Fjelstad AB, Hommelstad J, Sorteberg A. Infections related to intrathecal baclofen therapy in children and adults: frequency and risk factors. J Neurosurg Pediatr. 2009;4(5):487\u2013493."},{"key":"b15","series-title":"Touch Neurology","article-title":"Troubleshooting for intrathecal baclofen therapy","author":"Cooper JA","year":"2011","unstructured":"Cooper JA. Troubleshooting for intrathecal baclofen therapy. Touch Neurology; 2011. Accessed July 17, 2024.https:\/\/touchneurology.com\/troubleshooting-for-intrathecal-baclofen-therapy-2\/"},{"issue":"4","key":"b16","series-title":"J Neurosurg Pediatr","first-page":"395","article-title":"A standardized protocol to reduce pediatric baclofen pump infections: a quality improvement initiative","volume":"21","author":"Desai VR","year":"2018","unstructured":"Desai VR, Raskin JS, Mohan A,  A standardized protocol to reduce pediatric baclofen pump infections: a quality improvement initiative. J Neurosurg Pediatr. 2018;21(4):395\u2013400."},{"issue":"3","key":"b17","series-title":"Pediatr Neurosurg","first-page":"138","article-title":"Complications of intrathecal baclofen pumps in children: experience from a tertiary care center","volume":"49","author":"Ghosh D","year":"2013","unstructured":"Ghosh D, Mainali G, Khera J, Luciano M. Complications of intrathecal baclofen pumps in children: experience from a tertiary care center. Pediatr Neurosurg. 2013;49(3):138\u2013144."},{"issue":"7","key":"b18","series-title":"Pediatr Infect Dis J","first-page":"715","article-title":"Infectious complications of intrathecal baclofen pump devices in a pediatric population","volume":"32","author":"Dickey MP","year":"2013","unstructured":"Dickey MP, Rice M, Kinnett DG,  Infectious complications of intrathecal baclofen pump devices in a pediatric population. Pediatr Infect Dis J. 2013;32(7):715\u2013722."},{"issue":"6","key":"b19","series-title":"J Neurosurg Pediatr","first-page":"756","article-title":"Risk factors for baclofen pump infection in children: a multivariate analysis","volume":"17","author":"Spader HS","year":"2016","unstructured":"Spader HS, Bollo RJ, Bowers CA, Riva-Cambrin J. Risk factors for baclofen pump infection in children: a multivariate analysis. J Neurosurg Pediatr. 2016;17(6):756\u2013762."},{"issue":"5","key":"b20","series-title":"Anesth Analg","first-page":"1435","article-title":"Preoperative vancomycin administration for surgical site prophylaxis: plasma and soft-tissue concentrations in pediatric neurosurgical and orthopedic patients","volume":"130","author":"Brooks Peterson M","year":"2020","unstructured":"Brooks Peterson M, Cohen MN, O\u2019Neill BR,  Preoperative vancomycin administration for surgical site prophylaxis: plasma and soft-tissue concentrations in pediatric neurosurgical and orthopedic patients. Anesth Analg. 2020;130(5):1435\u20131444."},{"key":"b21","series-title":"Synthese","first-page":"10969","article-title":"When to adjust alpha during multiple testing: a consideration of disjunction, conjunction, and individual testing","volume":"199","author":"Rubin M","year":"2021","unstructured":"Rubin M. When to adjust alpha during multiple testing: a consideration of disjunction, conjunction, and individual testing. Synthese. 2021;199:10969\u201311000."}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/34\/6\/article-p659.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/34\/6\/article-p659.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/34\/6\/article-p659.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T13:09:46Z","timestamp":1733490586000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/34\/6\/article-p659.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":21,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2024.6.peds23360","relation":{},"ISSN":["1933-0707","1933-0715"],"issn-type":[{"value":"1933-0707","type":"print"},{"value":"1933-0715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}